©istock.com/Andrea Obzerova
Interdisciplinary CompetenceMolecular Diagnostics
Know how in the analysis of genetic material.
For the benefit of patients.

IllnessGlomerulosclerosis, focal segmental; differential diagnosis

Summary

Short information

Comprehensive differential diagnostic panel for focal-segmental glomerulosklerossis comprising 3 guideline-curated genes, 7 core candidate genes and altogether 64 curated genes according to the clinical signs

ID
GP0150
Number of genes
48 Accredited laboratory test
Examined sequence length
30,6 kb (Core-/Core-canditate-Genes)
174,5 kb (Extended panel: incl. additional genes)
Analysis Duration
on request
Material
  • EDTA-anticoagulated blood (3-5 ml)
Diagnostic indications

NGS +

[Sanger]

 

Gene panel

Selected genes

NameExon Length (bp)OMIM-GHeredity
ACTN42736AD
CD2AP1920AR
COL4A35013AD, AR
COL4A45073AR
COL4A55058XLD
COQ8B1512AR
INF23750AD
NPHS21152AR
TRPC62796AD
WT11569AD
ALG11395AR
ANLN3375AD
APOL11197AR
ARHGAP242247n.k.
ARHGDIA615AR
COQ21266AR
COQ61407AR
CRB23858AR
CUBN10872AR
DGKE1704AR
EMP2504AR
FAT113767AR
FN17068AD
ITGA33156AR
ITGB45259n.k.
KANK22556AR
LAMA511088AR
LAMB25397AR
LMX1B1188AD
LRP213968AR
MAGI24368AR
MYH95883AD
MYO1E3327AR
NPHP44281AR
NPHS13726AR
NUP1072778AR
PAX21254AD
PDSS21200AR
PLCE16909AR
PMM2741AR
PODXL1677AD
PTPRO3651AR
SCARB21437AR
SMARCAL12865AR
SYNPO2058n.k.
TP53RK762AR
TTC21B3951AR
WDR731137AR

Informations about the disease

Clinical Comment

A pathologic finding in several renal disorders manifesting clinically as proteinuria + progressive renal dysfunction. Some patients develop nephrotic syndrome, which includes massive proteinuria, hypoalbuminemia, hyperlipidemia, edema. FSGS patients may have proteinuria in the nephrotic range without other features of nephrotic syndrome.

 

Synonyms
  • Alias: Focal segmental glomerulosclerosis; FSGS
  • Allelic: Cerebral palsy, spastic quadriplegic, 2 (KANK1)
  • Allelic: Deafness, AD 17 (MYH9)
  • Allelic: Denys-Drash-, Frasier-, Meacham syndrome; Mesothelioma, somatic; Wilms tumor, type 1 (WT1)
  • Allelic: Epidermolysis bullosa of hands and feet (ITGB4)
  • Allelic: Epidermolysis bullosa, junctional, non-Herlitz type (ITGB4)
  • Allelic: Epidermolysis bullosa, junctional, with pyloric atresia (ITGB4)
  • Allelic: Hematuria, benign familial (COL4A3, COL4A4)
  • Allelic: Palmoplantar keratoderma + woolly hair (KANK2)
  • Allelic: Short-rib thoracic dysplasia 4 with/-out polydactyly (TTC21B)
  • Alport syndrome 1, XL (COL4A5)
  • Alport syndrome 2, AR (COL4A3, COL4A4)
  • Alport syndrome 3, AD (COL4A3)
  • Coenzyme Q10 deficiency, primary, 1 (COQ2)
  • Coenzyme Q10 deficiency, primary, 3 (PDSS2)
  • Coenzyme Q10 deficiency, primary, 6 (COQ6)
  • Congenital disorder of glycosylation, type Ia (PMM2)
  • Congenital disorder of glycosylation, type Ik (ALG1)
  • Congenital nephrotic syndrome [panelapp green] (PODXL)
  • Donnai-Barrow syndrome (LRP2)
  • End-stage renal disease, nondiabetic, susceptibility to (APOL1)
  • Epidermolysis bullosa simplex 7, with nephropathy + deafness (CD151)
  • Epilepsy, progressive myoclonic 4, with/-out renal failure (SCARB2)
  • Focal segmental glomerulosclerosis + neurodevelopmental syndrome (TRIM8)
  • Focal segmental glomerulosclerosis 10 (LMX1B)
  • Focal segmental glomerulosclerosis 8 (ANLN)
  • Focal segmental glomerulosclerosis 9 (CRB2)
  • Focal segmental glomerulosclerosis [panelapp red] (E2F3)
  • Focal segmental glomerulosclerosis [panelapp red] (SYNPO)
  • Galloway-Mowat syndrome 1 (WDR73)
  • Galloway-Mowat syndrome 2, XL (LAGE3)
  • Galloway-Mowat syndrome 3 (OSGEP)
  • Galloway-Mowat syndrome 4 (TP53RK)
  • Galloway-Mowat syndrome 5 (TPRKB)
  • Galloway-Mowat syndrome 7 (NUP107)
  • Galloway-Mowat syndrome 8 (NUP133)
  • Glomerulopathy with fibronectin deposits 2 (FN1)
  • Glomerulosclerosis, focal segmental, 1 (ACTN4)
  • Glomerulosclerosis, focal segmental, 2 (TRPC6)
  • Glomerulosclerosis, focal segmental, 3 (CD2AP)
  • Glomerulosclerosis, focal segmental, 4, susceptibility to (APOL1)
  • Glomerulosclerosis, focal segmental, 5 (INF2)
  • Glomerulosclerosis, focal segmental, 6 (MYO1E)
  • Glomerulosclerosis, focal segmental, 7 (PAX2)
  • Glomerulotubular nephropathy [panelapp] (FAT1)
  • Hemolytic uremic syndrome, atypical, susceptibility to, 7 (DGKE)
  • Imerslund-Grasbeck syndrome 1 (CUBN)
  • Interstitial lung disease, nephrotic syndrome, epidermolysis bullosa, congenital (ITGA3)
  • Macrothrombocytopenia + granulocyte inclus. with/-out nephritis or sensorineural hearing loss (MYH9)
  • Nail-patella syndrome (LMX1B)
  • Nephronophthisis 12 (TTC21B)
  • Nephronophthisis 4 (NPHP4)
  • Nephrotic syndrome [panelapp] (LAMA5)
  • Nephrotic syndrome [panelapp] (XPO5)
  • Nephrotic syndrome, type 1 (NPHS1)
  • Nephrotic syndrome, type 10 (EMP2)
  • Nephrotic syndrome, type 11 (NUP107)
  • Nephrotic syndrome, type 12 (NUP93)
  • Nephrotic syndrome, type 13 (NUP205)
  • Nephrotic syndrome, type 14 (SGPL1)
  • Nephrotic syndrome, type 15 (MAGI2)
  • Nephrotic syndrome, type 16 (KANK2)
  • Nephrotic syndrome, type 17 (NUP85)
  • Nephrotic syndrome, type 18 (NUP133)
  • Nephrotic syndrome, type 19 (NUP160)
  • Nephrotic syndrome, type 2 (NPHS2)
  • Nephrotic syndrome, type 20 (TBC1D8B)
  • Nephrotic syndrome, type 21 (AVIL)
  • Nephrotic syndrome, type 3 (PLCE1)
  • Nephrotic syndrome, type 4 (WT1)
  • Nephrotic syndrome, type 5, with/-out ocular abnormalities (LAMB2)
  • Nephrotic syndrome, type 6 (PTPRO)
  • Nephrotic syndrome, type 7 (DGKE)
  • Nephrotic syndrome, type 8 (ARHGDIA)
  • Nephrotic syndrome, type 9 (COQ8B)
  • Papillorenal syndrome (PAX2)
  • Pierson syndrome (LAMB2)
  • Proteinuria, chronic benign (CUBN)
  • Proteinuric renal disease [panelapp] (GAPVD1)
  • Schimke immunoosseous dysplasia (SMARCAL1)
  • Senior-Loken syndrome 4 (NPHP4)
  • Steroid-resistant nephrotic syndrome [GeneReviews] (ANKFY1)
  • Ventriculomegaly with cystic kidney disease (CRB2)
Heredity, heredity patterns etc.
  • AD
  • AR
  • XLD
  • n.k.
OMIM-Ps
  • Multiple OMIM-Ps
ICD10 Code
N04.1

Bioinformatics and clinical interpretation

No text defined